CN Patent

CN108261411B — 用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法

Assigned to Wuhan Conform New Pharm Co ltd · Expires 2021-04-30 · 5y expired

What this patent protects

本发明提供了一种用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法，该用于婴幼儿血管瘤治疗的口腔膜剂包括β‑受体阻断剂以及药学上可接受的辅料。该口腔膜剂每片的药物含量准确，可实现方便、准确定量给药，便于患儿用药保证疗效，且完全适合工业化大生产。

USPTO Abstract

本发明提供了一种用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法，该用于婴幼儿血管瘤治疗的口腔膜剂包括β‑受体阻断剂以及药学上可接受的辅料。该口腔膜剂每片的药物含量准确，可实现方便、准确定量给药，便于患儿用药保证疗效，且完全适合工业化大生产。

Drugs covered by this patent

propranolol-hydrochloride (PROPRANOLOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN108261411B
Jurisdiction: CN
Classification: —
Expires: 2021-04-30
Drug substance claim: No
Drug product claim: No
Assignee: Wuhan Conform New Pharm Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.